Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
An insight into GPCR and G-proteins as cancer drivers
PK Chaudhary, S Kim - Cells, 2021 - mdpi.com
G-protein-coupled receptors (GPCRs) are the largest family of cell surface signaling
receptors known to play a crucial role in various physiological functions, including tumor …
receptors known to play a crucial role in various physiological functions, including tumor …
The renin–angiotensin system and cancer: old dog, new tricks
For cancers to develop, sustain and spread, the appropriation of key homeostatic
physiological systems that influence cell growth, migration and death, as well as …
physiological systems that influence cell growth, migration and death, as well as …
Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
Cancer and stromal cells actively exert physical forces (solid stress) to compress tumour
blood vessels, thus reducing vascular perfusion. Tumour interstitial matrix also contributes to …
blood vessels, thus reducing vascular perfusion. Tumour interstitial matrix also contributes to …
Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors
B Diop-Frimpong, VP Chauhan, S Krane… - Proceedings of the …, 2011 - pnas.org
The dense collagen network in tumors significantly reduces the penetration and efficacy of
nanotherapeutics. We tested whether losartan—a clinically approved angiotensin II receptor …
nanotherapeutics. We tested whether losartan—a clinically approved angiotensin II receptor …
Linking heart failure to cancer: background evidence and research perspectives
Recent epidemiological analyses suggest that incident cancer may be more common
among patients with preexisting heart failure (HF) than in patients without HF. Arguments …
among patients with preexisting heart failure (HF) than in patients without HF. Arguments …
The renin-angiotensin-aldosterone system (RAAS) signaling pathways and cancer: foes versus allies
The renin-angiotensin-aldosterone system (RAAS), is an old system with new fundamental
roles in cancer biology which influences cell growth, migration, death, and metastasis. RAAS …
roles in cancer biology which influences cell growth, migration, death, and metastasis. RAAS …
Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138 769 individuals
ARB Trialists Collaboration - Journal of hypertension, 2011 - journals.lww.com
Background Angiotensin-converting enzyme inhibitors (ACEi) and angiotensin II receptor
blockers (ARBs) reduce cardiovascular disease (CVD) events, but a recent meta-analysis of …
blockers (ARBs) reduce cardiovascular disease (CVD) events, but a recent meta-analysis of …
Drug combination and repurposing for cancer therapy: The example of breast cancer
AS Correia, F Gärtner, N Vale - Heliyon, 2021 - cell.com
Cancer is a set of extremely complex diseases, which are increasingly prominent today, as it
affects and kills millions of people worldwide, being the subject of intense study both in its …
affects and kills millions of people worldwide, being the subject of intense study both in its …
GENT: gene expression database of normal and tumor tissues
G Shin, TW Kang, S Yang, SJ Baek… - Cancer …, 2011 - journals.sagepub.com
Background Some oncogenes such as ERBB2 and EGFR are over-expressed in only a
subset of patients. Cancer outlier profile analysis is one of computational approaches to …
subset of patients. Cancer outlier profile analysis is one of computational approaches to …
Reduced risk of breast cancer recurrence in patients using ACE inhibitors, ARBs, and/or statins
YK Chae, ME Valsecchi, J Kim, AL Bianchi… - Cancer …, 2011 - Taylor & Francis
Background: Epidemiologic and biochemical evidence suggest a role of statins and
angiotensin-converting enzyme (ACE) inhibitors or angiotensin-receptor blockers (ARBs) as …
angiotensin-converting enzyme (ACE) inhibitors or angiotensin-receptor blockers (ARBs) as …